Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1
Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.
- Status
- UNKNOWN
- Phase
- PHASE3
Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Precoce Medical Care by the Mobil Support for Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- NA
A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- Status
- RECRUITING
- Phase
- NA
LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
- Status
- COMPLETED
- Phase
- NA
Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Infigratinib in Recurrent High-Grade Glioma Patients
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Tumor Electric Fields Treatment System for Glioblastoma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
VB-111 in Surgically Accessible Recurrent/Progressive GBM
- Status
- TERMINATED
- Phase
- PHASE2
Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1